63
Participants
Start Date
August 25, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Low-dose corticosteroids for immune-related hepatitis grade 3
Prednisolone 0.5-1 mg/kg orally for grade 3 IR-hepatitis; adjusted based on liver function; treatment per local standard of care.
Low-dose corticosteroids for immune-related hepatitis grade 2
Hold immunotherapy and reassess liver function at the treating physician's discretion. If liver function tests persistently worsen or continue to rise, consider administering prednisolone at 0.5 mg/kg body weight
RECRUITING
University Hospital Basel, Basel
NOT_YET_RECRUITING
Royal Marsden Hospital, London
Royal Marsden NHS Foundation Trust
OTHER
Odense University Hospital
OTHER
UMC Utrecht
OTHER
University Hospital, Basel, Switzerland
OTHER